United Therapeutics (UTHR) Misses Q2 EPS by 63c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $549.90 --0%
Revenue Growth %: +1.5%
Financial Fact:
Other, net: 1M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +1.5%
Financial Fact:
Other, net: 1M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $5.85, $0.63 worse than the analyst estimate of $6.48. Revenue for the quarter came in at $714.9 million versus the consensus estimate of $689.93 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
- Evertz Technology (ET:CN) (EVTZF) PT Raised to Cdn$18 at BMO Capital
- BofA Securities Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
